This content is from: United States

Ex-US Treasury officials: America’s new ‘inversion’ regulations will push US companies overseas

Eighteen ex-Treasury officials are lobbying US President Barack Obama to reconsider new ‘inversion’ rules announced after Pfizer’s failed $160 billion merger with Ireland’s Allergan, saying the regulations will encourage US companies to move abroad and exacerbate the problem.

To access our market-driven intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an ITR subscriber? Log in here

Instant access to all of our content. Membership Options | 30 Day Trial